
    
      To characterise features of the metabolic syndrome, including body fat, insulin sensitivity,
      and liver fat together with muscle micorvascular blood flow.

      To undertake a randomised controlled trial of atorvastatin 40 mg. o.d for 6 months to
      determine whether any of the above measures change with treatment.
    
  